Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
age-related macular degeneration
Pharma
Bristol Myers wins, Apellis loses in busy week at Europe's CHMP
Shortly after Europe’s CHMP recommended refusal of marketing authorization for Apellis’ Syfovre, the company said it will appeal.
Kevin Dunleavy
Jan 26, 2024 11:36am
Apellis' stumbling GA drug Syfovre shows signs of recovery
Oct 5, 2023 11:22am
Astellas touts 2-year trial of Izervay, but questions remain
Sep 19, 2023 11:32am
FDA rejects Outlook's Avastin reformulation for eye disease
Aug 30, 2023 11:30am
FDA approves Regeneron’s HD Eylea, triggering battle with Roche
Aug 21, 2023 11:01am
Novartis' Eylea biosimilar adds to pressure on Regeneron's star
Aug 15, 2023 11:25am